论文信息 - KIT Inhibitor Midostaurin Exhibits a High Rate of Clinically Meaningful and Durable Responses in Advanced Systemic Mastocytosis: Report of a Fully Accrued Phase II Trial - 字舞流文

KIT Inhibitor Midostaurin Exhibits a High Rate of Clinically Meaningful and Durable Responses in Advanced Systemic Mastocytosis: Report of a Fully Accrued Phase II Trial

T. Graubert | C. Corless | T. George | D. DeAngelo | J. Gotlib | Z. Nikolova | C. Dutreix | A. Linder | Daniel J. DeAngelo | S. Gross | C. Langford | Cheryl Langford | D. DeAngelo